<DOC>
	<DOCNO>NCT00913666</DOCNO>
	<brief_summary>This study look difference bioanalytical measure among different group MS patient Healthy Volunteers , administer interferon beta-1a .</brief_summary>
	<brief_title>Pharmacodynamic Study Better Understand Therapeutic Response Immunomodulatory Effects Avonex Multiple Sclerosis ( MS ) Patients Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-beta</mesh_term>
	<mesh_term>Interferon beta-1a</mesh_term>
	<criteria>Healthy Control Subjects ( Group 1 ) Must general good health . Must receive interferon past . All MS Subjects Clinical laboratorysupported diagnosis relapse remit MS ( McDonald et al , criterion number 14 ) . Either AVONEX® treatmentnaïve . Have EDSS score 0.0 5.5 , inclusive . History severe allergic anaphylactic reaction hypersensitivity human albumin , interferon , component drug formulation . History intolerance acetaminophen , ibuprofen , naproxen , aspirin would preclude use least one study . History clinically significant ( determined investigator ) cardiac , endocrinologic , hematologic , hepatic , immunologic , metabolic , urologic , pulmonary , neurologic , dermatologic , psychiatric , renal , and/or major disease . History malignancy . The presence significant medical condition psychiatric illness due MS , investigator 's opinion , would interfere therapy History uncontrolled seizure within 3 month prior enrollment . History suicidal ideation episode severe depression within 3 month prior enrollment . Serious local infection ( e.g. , cellulitis , abscess ) systemic infection ( e.g. , pneumonia , septicemia ) within 8 week prior enrollment . Positive human immunodeficiency virus ( HIV ) , hepatitis C antibody ( HCV ) positive hepatitis B surface antigen ( HbsAg ) screening . Other inclusion exclusion criterion apply per protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>Multiple Sclerosis</keyword>
</DOC>